A prospective cohort study of children's Feireqing granules in children with bronchial asthma attack induced by respiratory tract infection based on the Chinese Children's Asthma Action Plan and realistic medical environment
- Conditions
- Respiratory tract infection induced bronchial asthma attack in children
- Registration Number
- ITMCTR2100005288
- Lead Sponsor
- Shanghai Hospital of Traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
(1) Children with asthma attack induced by respiratory tract infection.
(2) 3 ~ 13 years old (< 14 years old).
(3) The informed consent process should comply with regulations. For children who agreed to add Infantile Fereqing Granule, the informed consent was signed by the legal guardian of the children aged 8 and above and the informed consent was signed by the legal guardian of the children under 8 years old.
(4) The child and his/her guardian agree to use the Leisurely Breathing APP.
(1) Other diseases that may cause asthma or dyspnea, such as bronchiolitis, pneumonia, etc.
(2) severe asthma attack, into the red zone children: ? severe cough, choking, dyspnea, three concave sign positive; ? Walking, language difficulties, can not recumbent; (3) the nose wing flapping, cyanosis; (4) crying, restlessness, anxiety, lethargy, lethargy, and even vague consciousness; ?PEF < 60% expected value.
(3) The researcher thinks it is not appropriate to enter this study.
Study & Design
- Study Type
- Observational study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Asthma attack control time/ratio;
- Secondary Outcome Measures
Name Time Method